ACR Meeting Abstracts
Abstract Number: 1986 • ACR/ARP Annual Meeting 2019
Clara Sanjurjo-Rodríguez 1, Rachel Crossland 2, Thomas Baboolal 3, Monica Reis 4, Agata Burska 5, Frederique Ponchel 5, Jehan El-Jawhari 5, Dennis McGonagle6, Hemant Pandit 7, Xiao-nong Wang 8 and Elena Jones 9, 1Grupo de investigación en Terapia Celular y Medicina Regenerativa. Departamento de Fisioterapia, Medicina y Ciencias Biomédicas. Universidade da Coruña. Agrupación estratégica CICA-INIBIC. A Coruña, España; University of Leeds; Newcastle University, A Coruña, Spain, 22Institute of Cellular Medicine, Newcastle University, Newcastle, United Kingdom, 3Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM)University of Leeds, Leeds, United Kingdom, 4Department of Pediatrics, Harvard Medical School, Boston, MA, USA, Boston, 5Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 6University of Leeds, Leeds, United Kingdom, 7Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds. NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 8Institute of Cellular Medicine, Newcastle University, UK, Newcastle, United Kingdom, 9University of Leeds, Leeds, England, United Kingdom
Background/Purpose: Bone marrow multipotential stromal cells (MSC) are widely used in clinical trials to treat bone and cartilage diseases. However, there is limited information on…